KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Equity Ratio (2018 - 2021)

BioNTech SE's Equity Ratio history spans 4 years, with the latest figure at 0.75 for Q4 2021.

  • On a quarterly basis, Equity Ratio rose 26.98% to 0.75 in Q4 2021 year-over-year; TTM through Dec 2021 was 0.75, a 26.98% increase, with the full-year FY2021 number at 0.75, up 26.98% from a year prior.
  • Equity Ratio hit 0.75 in Q4 2021 for BioNTech SE, up from 0.59 in the prior quarter.
  • Over the last five years, Equity Ratio for BNTX hit a ceiling of 0.75 in Q4 2021 and a floor of 0.41 in Q4 2018.
  • Historically, Equity Ratio has averaged 0.59 across 4 years, with a median of 0.61 in 2019.
  • Biggest five-year swings in Equity Ratio: soared 51.31% in 2019 and later dropped 4.37% in 2020.
  • Tracing BNTX's Equity Ratio over 4 years: stood at 0.41 in 2018, then surged by 51.31% to 0.62 in 2019, then dropped by 4.37% to 0.59 in 2020, then grew by 26.98% to 0.75 in 2021.
  • Business Quant data shows Equity Ratio for BNTX at 0.75 in Q4 2021, 0.59 in Q4 2020, and 0.62 in Q4 2019.